Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Powell

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samplesDaniel J Powell, Linda L Parker, Steven A Rosenberg
Cancer Immunology Research|June 27, 2015
Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for CancerKatarzyna Urbanska, Caitlin Stashwick, Mathilde Poussin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
A thyroid tumor-specific antigen formed by the fusion of two self proteinsDaniel J Powell, Laurence C Eisenlohr, Jay L Rothstein
Gynecologic Oncology|April 11, 2024
Adoptive T cell therapy for ovarian cancerSarah B Gitto, Chibuike J N Ihewulezi, Daniel J Powell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Immunotherapy for ovarian cancer: what's next?Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
Journal of Hematology & Oncology|July 8, 2018
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cellsYali Han, Wei Xie, De-Gang Song, et al.
Nature Reviews. Immunology|April 20, 2006
Adoptive immunotherapy for cancer: building on successLuca Gattinoni, Daniel J Powell, Steven A Rosenberg, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2021
Humanized Patient-Derived Xenograft Models of Ovarian CancerSarah B Gitto, Erin George, Sergey Medvedev, et al.
Gynecologic Oncology|April 6, 2017
T-cell target antigens across major gynecologic cancersAlba Rodriguez-Garcia, Nicholas G Minutolo, John M Robinson, et al.
European Journal of Immunology|September 10, 2021
Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILsMonika A Eiva, Dalia K Omran, Jessica A Chacon, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samplesDaniel J Powell, Linda L Parker, Steven A Rosenberg
Cancer Immunology Research|June 27, 2015
Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for CancerKatarzyna Urbanska, Caitlin Stashwick, Mathilde Poussin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
A thyroid tumor-specific antigen formed by the fusion of two self proteinsDaniel J Powell, Laurence C Eisenlohr, Jay L Rothstein
Gynecologic Oncology|April 11, 2024
Adoptive T cell therapy for ovarian cancerSarah B Gitto, Chibuike J N Ihewulezi, Daniel J Powell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Immunotherapy for ovarian cancer: what's next?Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
Journal of Hematology & Oncology|July 8, 2018
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cellsYali Han, Wei Xie, De-Gang Song, et al.
Nature Reviews. Immunology|April 20, 2006
Adoptive immunotherapy for cancer: building on successLuca Gattinoni, Daniel J Powell, Steven A Rosenberg, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2021
Humanized Patient-Derived Xenograft Models of Ovarian CancerSarah B Gitto, Erin George, Sergey Medvedev, et al.
Gynecologic Oncology|April 6, 2017
T-cell target antigens across major gynecologic cancersAlba Rodriguez-Garcia, Nicholas G Minutolo, John M Robinson, et al.
European Journal of Immunology|September 10, 2021
Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILsMonika A Eiva, Dalia K Omran, Jessica A Chacon, et al.
Pageof 14